Last 12 months
Inside the activity.
0 purchase rows · 25 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 12, 2020 Filed Mar 25, 2020 01:09 UTC |
Benjamin Richard JChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 15,833 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-021044 · doc4.xml · derivative · entry 8 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,833 Underlying: Common Stock · 15,833 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F4 · price: Not applicable. F5 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. F5 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. Read SEC document |
| March 12, 2020 Filed Mar 25, 2020 01:09 UTC |
Benjamin Richard JChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 7,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-021044 · doc4.xml · derivative · entry 7 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F4 · price: Not applicable. F3 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. F3 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. Read SEC document |
| March 12, 2020 Filed Mar 25, 2020 01:29 UTC |
Moore CarolSVP Reg. & Quality
|
Exercise / conversionRestricted Stock Unit · Derivative | 45,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-021050 · doc4.xml · derivative · entry 9 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 45,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F7 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2020. F7 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2020. Read SEC document |
| March 12, 2020 Filed Mar 25, 2020 01:29 UTC |
Moore CarolSVP Reg. & Quality
|
Exercise / conversionRestricted Stock Unit · Derivative | 15,833 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-021050 · doc4.xml · derivative · entry 8 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,833 Underlying: Common Stock · 15,833 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F6 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. F6 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. Read SEC document |
| March 12, 2020 Filed Mar 25, 2020 01:29 UTC |
Moore CarolSVP Reg. & Quality
|
Exercise / conversionRestricted Stock Unit · Derivative | 7,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-021050 · doc4.xml · derivative · entry 7 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. F4 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. Read SEC document |
| March 12, 2020 Filed Mar 25, 2020 01:24 UTC |
Jayaraman Vivek KChief Commercial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 45,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-021048 · doc4.xml · derivative · entry 8 Jayaraman Vivek K · CIK 0001605456 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 45,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F7 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2020. F7 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2020. Read SEC document |
| March 12, 2020 Filed Mar 25, 2020 01:24 UTC |
Jayaraman Vivek KChief Commercial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 15,833 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-021048 · doc4.xml · derivative · entry 7 Jayaraman Vivek K · CIK 0001605456 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,833 Underlying: Common Stock · 15,833 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F6 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. F6 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. Read SEC document |
| March 12, 2020 Filed Mar 25, 2020 01:24 UTC |
Jayaraman Vivek KChief Commercial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-021048 · doc4.xml · derivative · entry 6 Jayaraman Vivek K · CIK 0001605456 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. F4 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. Read SEC document |
| March 12, 2020 Filed Mar 25, 2020 01:19 UTC |
Greenman William MarinerDirector · President and CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 151,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-021047 · doc4.xml · derivative · entry 9 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 303,333 Underlying: Common Stock · 151,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F7 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2020. F7 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2020. Read SEC document |
| March 12, 2020 Filed Mar 25, 2020 01:19 UTC |
Greenman William MarinerDirector · President and CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 71,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-021047 · doc4.xml · derivative · entry 8 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,666 Underlying: Common Stock · 71,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F6 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. F6 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. Read SEC document |
| March 12, 2020 Filed Mar 25, 2020 01:19 UTC |
Greenman William MarinerDirector · President and CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 28,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-021047 · doc4.xml · derivative · entry 7 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. F4 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. Read SEC document |
| March 12, 2020 Filed Mar 25, 2020 01:15 UTC |
Green Kevin DennisChief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 45,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-021046 · doc4.xml · derivative · entry 9 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 45,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F4 · price: Not applicable. F6 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2020. F6 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2020. Read SEC document |
| March 12, 2020 Filed Mar 25, 2020 01:15 UTC |
Green Kevin DennisChief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 15,833 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-021046 · doc4.xml · derivative · entry 8 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,833 Underlying: Common Stock · 15,833 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F4 · price: Not applicable. F5 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. F5 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. Read SEC document |
| March 12, 2020 Filed Mar 25, 2020 01:15 UTC |
Green Kevin DennisChief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 7,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-021046 · doc4.xml · derivative · entry 7 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F4 · price: Not applicable. F3 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. F3 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 23:12 UTC |
NACHTSHEIM JAMI KDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 5,128 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-017031 · doc4.xml · derivative · entry 2 NACHTSHEIM JAMI K · CIK 0001223017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,254 Underlying: Common Stock · 5,128 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F3 · price: Not applicable. F2 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on anniversary of the date of grant. F2 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on anniversary of the date of grant. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 23:12 UTC |
NACHTSHEIM JAMI KDirector
|
Exercise / conversionCommon Stock | 5,128 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-017031 · doc4.xml · nonDerivative · entry 1 NACHTSHEIM JAMI K · CIK 0001223017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,538 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 02, 2020 Filed Mar 16, 2021 23:18 UTC |
Moore CarolSVP Reg. & Quality
|
GrantRestricted Stock Unit · Derivative | 69,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021123 · doc4.xml · derivative · entry 2 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,000 Underlying: Common Stock · 69,000 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F2 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2021. F4 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2021. Read SEC document |
| March 02, 2020 Filed Mar 16, 2021 23:18 UTC |
Moore CarolSVP Reg. & Quality
|
GrantOption (Right to Buy) · Derivative | 138,000 | Not disclosed Strike: $5.11 | Not disclosed |
DisclosureSEC source: 0001209191-21-021123 · doc4.xml · derivative · entry 1 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,000 Underlying: Common Stock · 138,000 shares Expires 2030-03-01 F2 · price: Not applicable. F1 · derivative.exercise_date: One fourth (1/4th) of the shares subject to the Option shall vest on the first anniversary of the date of grant, and one forty-eighth (1/48th) of the shares subject to the Option vest monthly thereafter. Read SEC document |
| March 02, 2020 Filed Mar 16, 2021 23:06 UTC |
Green Kevin DennisChief Financial Officer
|
GrantRestricted Stock Unit · Derivative | 69,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021110 · doc4.xml · derivative · entry 2 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,000 Underlying: Common Stock · 69,000 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F2 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2021. F4 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2021. Read SEC document |
| March 02, 2020 Filed Mar 16, 2021 23:06 UTC |
Green Kevin DennisChief Financial Officer
|
GrantOption (Right to Buy) · Derivative | 138,000 | Not disclosed Strike: $5.11 | Not disclosed |
DisclosureSEC source: 0001209191-21-021110 · doc4.xml · derivative · entry 1 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,000 Underlying: Common Stock · 138,000 shares Expires 2030-03-01 F2 · price: Not applicable. F1 · derivative.exercise_date: One fourth (1/4th) of the shares subject to the Option shall vest on the first anniversary of the date of grant, and one forty-eighth (1/48th) of the shares subject to the Option vest monthly thereafter. Read SEC document |
| March 02, 2020 Filed Mar 16, 2021 23:15 UTC |
Jensen ChrystalChief Legal Officer
|
GrantRestricted Stock Unit · Derivative | 69,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021120 · doc4.xml · derivative · entry 2 Menard Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,000 Underlying: Common Stock · 69,000 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F2 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2021. F4 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2021. Read SEC document |
| March 02, 2020 Filed Mar 16, 2021 23:15 UTC |
Jensen ChrystalChief Legal Officer
|
GrantOption (Right to Buy) · Derivative | 138,000 | Not disclosed Strike: $5.11 | Not disclosed |
DisclosureSEC source: 0001209191-21-021120 · doc4.xml · derivative · entry 1 Menard Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,000 Underlying: Common Stock · 138,000 shares Expires 2030-03-01 F2 · price: Not applicable. F1 · derivative.exercise_date: One fourth (1/4th) of the shares subject to the Option shall vest on the first anniversary of the date of grant, and one forty-eighth (1/48th) of the shares subject to the Option vest monthly thereafter. Read SEC document |
| March 02, 2020 Filed Mar 16, 2021 23:14 UTC |
Jayaraman Vivek KChief Operating Officer
|
GrantRestricted Stock Unit · Derivative | 130,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021117 · doc4.xml · derivative · entry 2 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,000 Underlying: Common Stock · 130,000 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F2 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2021. F4 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2021. Read SEC document |
| March 02, 2020 Filed Mar 16, 2021 23:14 UTC |
Jayaraman Vivek KChief Operating Officer
|
GrantOption (Right to Buy) · Derivative | 260,000 | Not disclosed Strike: $5.11 | Not disclosed |
DisclosureSEC source: 0001209191-21-021117 · doc4.xml · derivative · entry 1 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,000 Underlying: Common Stock · 260,000 shares Expires 2030-03-01 F2 · price: Not applicable. F1 · derivative.exercise_date: One fourth (1/4th) of the shares subject to the Option shall vest on the first anniversary of the date of grant, and one forty-eighth (1/48th) of the shares subject to the Option vest monthly thereafter. Read SEC document |
| March 02, 2020 Filed Mar 16, 2021 23:05 UTC |
Greenman William MarinerDirector · President and CEO
|
GrantRestricted Stock Unit · Derivative | 316,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021107 · doc4.xml · derivative · entry 2 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 316,250 Underlying: Common Stock · 316,250 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F2 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2021. F4 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2021. Read SEC document |
| March 02, 2020 Filed Mar 16, 2021 23:05 UTC |
Greenman William MarinerDirector · President and CEO
|
GrantOption (Right to Buy) · Derivative | 632,500 | Not disclosed Strike: $5.11 | Not disclosed |
DisclosureSEC source: 0001209191-21-021107 · doc4.xml · derivative · entry 1 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 632,500 Underlying: Common Stock · 632,500 shares Expires 2030-03-01 F2 · price: Not applicable. F1 · derivative.exercise_date: One fourth (1/4th) of the shares subject to the Option shall vest on the first anniversary of the date of grant, and one forty-eighth (1/48th) of the shares subject to the Option vest monthly thereafter. Read SEC document |
| March 02, 2020 Filed Mar 16, 2021 23:03 UTC |
CORASH LAURENCE MChief Scientific Officer
|
GrantRestricted Stock Unit · Derivative | 69,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021103 · doc4.xml · derivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,000 Underlying: Common Stock · 69,000 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F2 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2021. F4 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2021. Read SEC document |
| March 02, 2020 Filed Mar 16, 2021 23:03 UTC |
CORASH LAURENCE MChief Scientific Officer
|
GrantOption (Right to Buy) · Derivative | 138,000 | Not disclosed Strike: $5.11 | Not disclosed |
DisclosureSEC source: 0001209191-21-021103 · doc4.xml · derivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,000 Underlying: Common Stock · 138,000 shares Expires 2030-03-01 F2 · price: Not applicable. F1 · derivative.exercise_date: One fourth (1/4th) of the shares subject to the Option shall vest on the first anniversary of the date of grant, and one forty-eighth (1/48th) of the shares subject to the Option vest monthly thereafter. Read SEC document |
| March 02, 2020 Filed Mar 16, 2021 23:01 UTC |
Benjamin Richard JChief Medical Officer
|
GrantRestricted Stock Unit · Derivative | 69,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021101 · doc4.xml · derivative · entry 2 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,000 Underlying: Common Stock · 69,000 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F2 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2021. F4 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2021. Read SEC document |
| March 02, 2020 Filed Mar 16, 2021 23:01 UTC |
Benjamin Richard JChief Medical Officer
|
GrantOption (Right to Buy) · Derivative | 138,000 | Not disclosed Strike: $5.11 | Not disclosed |
DisclosureSEC source: 0001209191-21-021101 · doc4.xml · derivative · entry 1 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,000 Underlying: Common Stock · 138,000 shares Expires 2030-03-01 F2 · price: Not applicable. F1 · derivative.exercise_date: One fourth (1/4th) of the shares subject to the Option shall vest on the first anniversary of the date of grant, and one forty-eighth (1/48th) of the shares subject to the Option vest monthly thereafter. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 22:54 UTC |
MOORE TIMOTHY L.Director
|
PurchaseCommon Stock | 3,614 | $4.75 | $17,165.05 |
DisclosureSEC source: 0001209191-20-009371 · doc4.xml · nonDerivative · entry 1 MOORE TIMOTHY L. · CIK 0001669207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,911 F1 · price: The reported price in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.745 to $4.75 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the aforementioned range set forth. Read SEC document |
| January 29, 2020 Filed Feb 4, 2020 01:21 UTC |
MOORE TIMOTHY L.Director
|
PurchaseCommon Stock | 3,614 | $4.15 | $14,998.10 |
DisclosureSEC source: 0001209191-20-006144 · doc4.xml · nonDerivative · entry 1 MOORE TIMOTHY L. · CIK 0001669207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,911 Read SEC document |
| January 29, 2020 Filed Feb 4, 2020 01:20 UTC |
ANDERSON TIMOTHY BDirector
|
PurchaseCommon Stock | 9,639 | $4.15 | $40,001.85 |
DisclosureSEC source: 0001209191-20-006141 · doc4.xml · nonDerivative · entry 1 ANDERSON TIMOTHY B · CIK 0001124168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,498 Read SEC document |
| January 29, 2020 Filed Feb 4, 2020 01:17 UTC |
Witney FrankDirector
|
PurchaseCommon Stock | 24,096 | $4.15 | $99,998.40 |
DisclosureSEC source: 0001209191-20-006139 · doc4.xml · nonDerivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,305 Read SEC document |
| January 29, 2020 Filed Feb 4, 2020 01:18 UTC |
NACHTSHEIM JAMI KDirector
|
PurchaseCommon Stock | 2,410 | $4.15 | $10,001.50 |
DisclosureSEC source: 0001209191-20-006140 · doc4.xml · nonDerivative · entry 1 NACHTSHEIM JAMI K · CIK 0001223017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,410 Read SEC document |
| January 29, 2020 Filed Feb 4, 2020 01:16 UTC |
BJERKHOLT ERICDirector
|
PurchaseCommon Stock | 20,000 | $4.15 | $83,000.00 |
DisclosureSEC source: 0001209191-20-006138 · doc4.xml · nonDerivative · entry 1 BJERKHOLT ERIC · CIK 0001197350 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,282 Read SEC document |
| January 29, 2020 Filed Feb 6, 2020 22:32 UTC |
Swisher Daniel N JRDirector
|
PurchaseCommon Stock | 1,000 | $4.15 | $4,150.00 |
DisclosureSEC source: 0001209191-20-007230 · doc4.xml · nonDerivative · entry 1 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,910 Read SEC document |
| January 29, 2020 Filed Feb 13, 2020 22:48 UTC Amendment |
MOORE TIMOTHY L.Director
|
PurchaseCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-009369 · doc4a.xml · nonDerivative · entry 1 MOORE TIMOTHY L. · CIK 0001669207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,297 F1 · ownership.direct: Amending to reverse purchase transaction that did not consummate. Read SEC document |
| December 04, 2019 Filed Dec 7, 2019 00:00 UTC |
SCHULZE GAILDirector
|
Exercise / conversionOption (Right to Buy) · Derivative | 15,000 | Not disclosed Strike: $1.80 | Not disclosed |
DisclosureSEC source: 0001209191-19-059532 · doc4.xml · derivative · entry 3 SCHULZE GAIL · CIK 0001023259 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2020-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Not applicable. F2 · derivative.exercise_date: The option became exercisable in 12 equal monthly installments after the grant date. Read SEC document |
| December 04, 2019 Filed Dec 7, 2019 00:00 UTC |
SCHULZE GAILDirector
|
SaleCommon Stock | 15,000 | $4.19 | $62,850.00 |
DisclosureSEC source: 0001209191-19-059532 · doc4.xml · nonDerivative · entry 2 SCHULZE GAIL · CIK 0001023259 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,986 F1 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.19 to $4.195 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| December 04, 2019 Filed Dec 7, 2019 00:00 UTC |
SCHULZE GAILDirector
|
Exercise / conversionCommon Stock | 15,000 | $1.80 | $27,000.00 |
DisclosureSEC source: 0001209191-19-059532 · doc4.xml · nonDerivative · entry 1 SCHULZE GAIL · CIK 0001023259 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,986 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 22:56 UTC |
CORASH LAURENCE MChief Scientific Officer
|
Exercise / conversionOption (Right to Buy) · Derivative | 13,000 | Not disclosed Strike: $3.75 | Not disclosed |
DisclosureSEC source: 0001209191-19-055013 · doc4.xml · derivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 13,000 shares Expires 2022-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Not applicable. F1 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested on the first day of each month thereafter. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 22:56 UTC |
CORASH LAURENCE MChief Scientific Officer
|
Exercise / conversionCommon Stock | 13,000 | $3.75 | $48,750.00 |
DisclosureSEC source: 0001209191-19-055013 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,751,925 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 25, 2019 Filed Oct 28, 2019 23:55 UTC |
CORASH LAURENCE MChief Scientific Officer
|
Exercise / conversionOption (Right to Buy) · Derivative | 12,000 | Not disclosed Strike: $3.75 | Not disclosed |
DisclosureSEC source: 0001209191-19-054287 · doc4.xml · derivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,000 Underlying: Common Stock · 12,000 shares Expires 2022-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Not applicable. F1 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested on the first day of each month thereafter. Read SEC document |
| October 25, 2019 Filed Oct 28, 2019 23:55 UTC |
CORASH LAURENCE MChief Scientific Officer
|
Exercise / conversionCommon Stock | 12,000 | $3.75 | $45,000.00 |
DisclosureSEC source: 0001209191-19-054287 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,738,925 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 09, 2019 Filed Oct 15, 2019 20:47 UTC |
CORASH LAURENCE MChief Scientific Officer
|
Exercise / conversionOption (Right to Buy) · Derivative | 30,000 | Not disclosed Strike: $3.75 | Not disclosed |
DisclosureSEC source: 0001209191-19-053169 · doc4.xml · derivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 30,000 shares Expires 2022-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Not applicable. F1 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested on the first day of each month thereafter. Read SEC document |
| October 09, 2019 Filed Oct 15, 2019 20:47 UTC |
CORASH LAURENCE MChief Scientific Officer
|
Exercise / conversionCommon Stock | 30,000 | $3.75 | $112,500.00 |
DisclosureSEC source: 0001209191-19-053169 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,726,925 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 04, 2019 Filed Oct 4, 2019 23:18 UTC |
BJERKHOLT ERICDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 4,282 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-052609 · doc4.xml · derivative · entry 2 BJERKHOLT ERIC · CIK 0001197350 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,562 Underlying: Common Stock · 4,282 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F3 · price: Not applicable. F2 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on anniversary of the date of grant. F2 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on anniversary of the date of grant. Read SEC document |
| October 04, 2019 Filed Oct 4, 2019 23:18 UTC |
BJERKHOLT ERICDirector
|
Exercise / conversionCommon Stock | 4,282 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-052609 · doc4.xml · nonDerivative · entry 1 BJERKHOLT ERIC · CIK 0001197350 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,282 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| October 02, 2019 Filed Oct 4, 2019 23:10 UTC |
CORASH LAURENCE MChief Scientific Officer
|
Exercise / conversionOption (Right to Buy) · Derivative | 30,000 | Not disclosed Strike: $3.75 | Not disclosed |
DisclosureSEC source: 0001209191-19-052608 · doc4.xml · derivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 30,000 shares Expires 2022-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Not applicable. F1 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested on the first day of each month thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.